Sportradar Reports Third Quarter 2026 Financial Results

Sportradar’s Q3 2026 revenue rose 24% to €363 million, while profit increased 20% to €27 million and Adjusted EBITDA grew 21% to €102 million, with a 28.2% margin. Net cash from operating activities increased 37% to €157 million and free cash flow rose 12% to €73 million. The company repurchased US$157 million of shares during the quarter and agreed to divest Atrium Sports for US$170 million.

Analysis

The key read-through is operating leverage with a quality check: adjusted EBITDA growth outpaced revenue growth, but the reported profit margin remains materially below the adjusted EBITDA margin. The call’s explanation of reconciliation items, segment mix, and whether cash generation is repeatable matters more than the headline growth rates. If growth is being bought through higher rights, data, or customer-acquisition costs, incremental margins could fade.

The Atrium Sports divestiture may sharpen focus and release capital, but its value depends on the revenue and earnings being surrendered, closing conditions, and use of proceeds; the sale price alone does not establish value creation. Repurchases support per-share results only if executed below intrinsic value and do not crowd out investment in data rights or product development.

Prediction-market partnerships offer distribution and data monetization upside, while creating a less obvious risk: expanded event-based trading may invite tighter scrutiny of market integrity, data usage, and jurisdictional rules. Any regulatory constraint could limit partner activity without directly invalidating Sportradar’s core sports-data business. Over 6–18 months, rights-cost inflation and contract renewals are the main structural margin risks. The provided highlights lack valuation, segment detail, guidance, and buyback execution prices, so they do not establish that the stock is cheap.

Key Decisions for Investors

• Treat the release as a modest positive, not a stand-alone chase signal. Consider a staged long in SRAD only if the earnings call confirms durable organic growth and stable or improving adjusted margins; absent valuation and guidance detail, size conservatively.
• Over the next 1–3 months, verify the Atrium transaction’s expected close, earnings contribution being divested, and proceeds plan. A proceeds-funded repurchase can support per-share value; a sale that removes attractive earnings or merely offsets weak cash generation would weaken the thesis.
• Monitor reported profit versus adjusted EBITDA, operating cash flow versus free cash flow, and commentary on rights costs and customer mix. Fading cash conversion or margin guidance cuts would falsify the operating-leverage thesis and argue for reducing exposure.
• Track regulatory developments and partner activity in prediction markets. Treat this as optional upside rather than a base-case valuation driver until monetization is demonstrated; adverse restrictions or evidence of elevated integrity/compliance costs would be a downside catalyst.